Inhalation-type pharmaceutical composition for treatment of parkinson's disease and preparation method thereof

一种帕金森氏症、吸入式的技术，应用在吸入式药物组合物及其制备领域，能够解决沉重负担等问题，达到增加药物吸收疗效的效果

Inactive Publication Date: 2015-09-30
林信涌
View PDF5 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this method of taking two lozenges at a time is a heavy burden for patients who have difficulty swallowing or symptoms of shaking

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Inhalation-type pharmaceutical composition for treatment of parkinson's disease and preparation method thereof
  • Inhalation-type pharmaceutical composition for treatment of parkinson's disease and preparation method thereof
  • Inhalation-type pharmaceutical composition for treatment of parkinson's disease and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0025] In order to make the advantages, spirit and characteristics of the present invention more easily and clearly understood, the following will be described and discussed in detail with reference to the accompanying drawings. It should be noted that these embodiments are only representative embodiments of the present invention, and the specific methods, devices, conditions, materials, etc. exemplified therein are not intended to limit the present invention or the corresponding embodiments.

[0026] The invention proposes an inhalation pharmaceutical composition for treating Parkinson's disease, which comprises a first gas and an atomized medicinal liquid. The first gas contains hydrogen, and the concentration of hydrogen in gas volume of the inhalation pharmaceutical composition is between 2% and 96%. The nebulized drug solution contains ingredients selected from Levodopa, Sinemet, Atropine Sulfate, Scopolamine, Dopamine Agonist, Bromocriptine Mesylate One or a combination...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides an inhalation-type pharmaceutical composition for gout and preparation method thereof, comprising a first gas and an atomized medicine. The first gas comprises hydrogen. The gas volume concentration of hydrogen in the inhalation-type pharmaceutical composition is between 2 to 96%. The atomized medicine is selected from a group comprising colchicine, allopurinol, probenecid, sulfinpyrazone, and any combination thereof. The inhalation-type pharmaceutical composition of the present invention can remove harmful radicals in the body of the patient through the use of hydrogen while also increases the absorption effect of the medicine for the patient by using an atomized medicine. At the same time, because the use of the small amount of the vaporized pharmaceutical liquid can indirectly reduce the side effects on the user.

Description

technical field [0001] The invention relates to an inhalation pharmaceutical composition and a preparation method thereof, in particular to an inhalation pharmaceutical composition for treating Parkinson's disease and a preparation method thereof. Background technique [0002] Regarding the known clinical symptoms of Parkinson's disease, it is observed that there are three main features, namely 1. tremor, 2. inability to move, and 3. stiffness and the like. Since the content of dopamine agonist (Dopamine Agonist) in the brain of patients with Parkinson's disease is found to be reduced, it is believed that the reduction of brain dopamine causes Parkinson's disease. Therefore, the treatment of Parkinson's disease is the administration of dopamine in the form of precursors, the regulation of dopamine metabolism or the use of dopamine agonists. Several drugs are known to treat Parkinson's disease, typical examples include Levodopa, Sinemet, Atropine Sulfate, Scopolamine, Dopami...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K33/00A61K45/00A61K9/72A61P25/16A61K31/198A61K31/46A61K31/48A61K31/137A61K31/277
CPCA61K31/635A61K47/02A61K9/0073A61K31/405A61K31/192A61K9/0004A61K31/46A61K31/48A61K31/5386A61K31/137A61K31/198A61K31/277A61P25/16A61K31/197A61K31/439A61K31/498A61K9/007A61K31/13A61K31/27A61K31/445A61K31/55A61K31/21A61K31/34A61K31/4365A61K31/4406A61K31/4422A61K31/554A61K31/616A61K31/165A61K31/4152A61K31/519
Inventor 林信涌
Owner 林信涌
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap